|
US3164597A
(en)
|
1962-12-17 |
1965-01-05 |
Geigy Chem Corp |
5-carboxylic acid-2-phenyl-pyrrolines, corresponding pyrrolidines and functional derivatives thereof
|
|
CH674205A5
(https=)
*
|
1988-05-11 |
1990-05-15 |
Lonza Ag |
|
|
IL94466A
(en)
|
1989-05-25 |
1995-01-24 |
Erba Carlo Spa |
Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
|
|
US6201016B1
(en)
|
1994-06-27 |
2001-03-13 |
Cytomed Incorporated |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
GB9618349D0
(en)
|
1996-09-03 |
1996-10-16 |
Pharmacia Spa |
N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity
|
|
IT1290910B1
(it)
|
1997-02-03 |
1998-12-14 |
Sigma Tau Ind Farmaceuti |
2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
|
|
GB9727523D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
|
TW502019B
(en)
|
1999-03-26 |
2002-09-11 |
Cocensys Inc |
Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
|
|
GB9923748D0
(en)
|
1999-10-07 |
1999-12-08 |
Glaxo Group Ltd |
Chemical compounds
|
|
IT1317049B1
(it)
|
2000-06-23 |
2003-05-26 |
Sigma Tau Ind Farmaceuti |
Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
PE20050077A1
(es)
|
2002-09-20 |
2005-03-01 |
Hoffmann La Roche |
Derivados de 4-pirrolidino-fenil-bencil-eter
|
|
MY142651A
(en)
|
2003-03-18 |
2010-12-15 |
Merck Sharp & Dohme |
Biaryl substituted triazoles as sodium channel blockers
|
|
US7589116B2
(en)
|
2003-04-03 |
2009-09-15 |
Merck & Co. Inc. |
Biaryl substituted pyrazoles as sodium channel blockers
|
|
CA2522476A1
(en)
|
2003-04-18 |
2004-11-04 |
Merck & Co., Inc. |
Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
EP1524265A1
(en)
|
2003-10-15 |
2005-04-20 |
Newron Pharmaceuticals S.p.A. |
Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors
|
|
WO2005110982A2
(en)
|
2004-04-07 |
2005-11-24 |
Neurogen Corporation |
Substituted 1-benzyl-4-substituted piperazine analogues
|
|
WO2005100334A1
(en)
|
2004-04-14 |
2005-10-27 |
Pfizer Products Inc. |
Dipeptidyl peptidase-iv inhibitors
|
|
JP2008540443A
(ja)
|
2005-05-04 |
2008-11-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
イオンチャネルのモジュレーターとして有用なピリミジンおよびピラジン
|
|
WO2006119390A1
(en)
|
2005-05-04 |
2006-11-09 |
Vertex Pharmaceuticals Incorporated |
Pyridines useful as modulators of ion channels
|
|
JP2008540665A
(ja)
|
2005-05-19 |
2008-11-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
イオンチャネルのモジュレーターとして有用なビアリール
|
|
EA013909B1
(ru)
|
2005-09-09 |
2010-08-30 |
Смитклайн Бичам Корпорейшн |
Пиридиновые производные и их применение для лечения психотических расстройств
|
|
TW200728258A
(en)
|
2005-10-10 |
2007-08-01 |
Glaxo Group Ltd |
Novel compounds
|
|
TW200730494A
(en)
*
|
2005-10-10 |
2007-08-16 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1943216B1
(en)
|
2005-10-10 |
2010-06-30 |
Glaxo Group Limited |
Prolinamide derivatives as sodium channel modulators
|
|
JP5182088B2
(ja)
*
|
2006-04-19 |
2013-04-10 |
アステラス製薬株式会社 |
アゾールカルボキサミド誘導体
|
|
JP2007290973A
(ja)
*
|
2006-04-21 |
2007-11-08 |
Univ Nagoya |
亜鉛−マグネシウムアート錯体を含む求核試薬及びそれを使用する求核付加体の製造方法
|
|
GB0701366D0
(en)
|
2007-01-24 |
2007-03-07 |
Glaxo Group Ltd |
Novel pharmaceutical compositions
|
|
EP2117538A1
(en)
|
2007-01-24 |
2009-11-18 |
Glaxo Group Limited |
Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
|
|
GB0701365D0
(en)
|
2007-01-24 |
2007-03-07 |
Glaxo Group Ltd |
Novel pharmaceutical compositions
|
|
GB0706630D0
(en)
|
2007-04-04 |
2007-05-16 |
Glaxo Group Ltd |
Novel compounds
|
|
DK2477964T5
(en)
|
2009-09-14 |
2015-05-26 |
Convergence Pharmaceuticals |
A process for the preparation of alpha-carboxamide
|
|
US20110144081A1
(en)
*
|
2009-12-15 |
2011-06-16 |
Henner Knust |
Pyrrolidine derivatives
|
|
WO2011155337A1
(ja)
|
2010-06-11 |
2011-12-15 |
シャープ株式会社 |
液晶装置
|
|
ES2428439T1
(es)
*
|
2010-11-11 |
2013-11-07 |
Aarti Healthcare Limited |
Un procedimiento para la preparación de Ramipril
|
|
ES2912881T3
(es)
*
|
2014-12-23 |
2022-05-30 |
Convergence Pharmaceuticals |
Procedimiento para preparar derivados de alfa-carboxamida pirrolidina
|
|
WO2016160574A2
(en)
|
2015-03-27 |
2016-10-06 |
Scifluor Life Sciences, Inc. |
Aryl- and heteroaryl-pyrrolidine-2-carboxamide compounds
|
|
CN106467513A
(zh)
*
|
2016-09-30 |
2017-03-01 |
陕西科技大学 |
一种制备Niraparib的合成方法
|
|
US11192856B2
(en)
|
2017-10-05 |
2021-12-07 |
Biogen Inc. |
Process for preparing alpha-carboxamide pyrrolidine derivatives
|
|
WO2020210486A1
(en)
|
2019-04-10 |
2020-10-15 |
Biogen Inc. |
Processes for preparing alpha-carboxamide pyrrolidine derivatives
|
|
CN114026066A
(zh)
|
2019-04-10 |
2022-02-08 |
生物基因麻省公司 |
制备α-甲酰胺吡咯烷衍生物的方法
|